It is also an ingredient in the European product Neo Borocillina. A low-pH throat lozenge containing dichlorobenzyl alcohol (1.2 mg) and amylmetacresol (0.6 mg) has been found to deactivate respiratory syncytial virus and SARS-Cov, but not adenovirus or rhinovirus.
Dichlorobenzyl alcohol (1.2 mg) and amylmetacresol (0.6 mg), which are components of the European product Neo Borocillina, can deactivate respiratory syncytial virus and SARS-Cov but not adenovirus or rhinovirus when used in a low-pH throat lozenge.